Recent Quotes
My Watchlist
Indicators
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NeuroOne Medical Technologies Corporation - Common Stock (NQ:NMTC)

3.480 +0.010 (+0.29%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about NeuroOne Medical Technologies Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
NeuroOne (NMTC) Q2 2026 Earnings Transcript ↗
Via The Motley Fool
News headline image
NeuroOne(R) to Present at the 2026 American Society for Stereotactic and Functional Neurosurgery Biennial Meeting on May 31, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
NeuroOne(R) to Present at the 2026 American Society for Stereotactic and Functional Neurosurgery Biennial Meeting on May 31, 2026
EDEN PRAIRIE, MINN. - May 28, 2026 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company dedicated to transforming the... 
Via TheNewswire.com
News headline image
NeuroOne(R) Medical Technologies Announces Restatement of Financial Results for Quarter Ending March 31, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
NeuroOne Medical Technologies (NASDAQ:NMTC) Fiscal Q2 Revenue Surges 72% But Misses Estimates, Shares Dip ↗
Via Chartmill
NeuroOne(R) Issues Shareholder Letter and Provides Corporate Update
Commercial Momentum Accelerates with Record OneRF® Procedure Volume in Fiscal Q1 ‘26 and Early Trigeminal Success 
Via TheNewswire.com
NeuroOne(R) Medical Technologies Announces Restatement of Financial Results for Quarter Ending March 31, 2026
Ongoing Business Not Affected, Company Reaffirms Product Revenue Guidance of at Least $10.5 Million for Fiscal Year 2026 
Via TheNewswire.com
News headline image
NeuroOne Reports Fiscal Q2 2026 Financial Results and Provides Corporate Business Update
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Economy
NeuroOne Reports Fiscal Q2 2026 Financial Results and Provides Corporate Business Update
Product Revenue of $2.4 Million up 72% Year Over Year 
Via TheNewswire.com
Topics Economy
NeuroOne(R) Regains Compliance With Nasdaq Listing Requirement
EDEN PRAIRIE, MINN. - May 4, 2026 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company dedicated to transforming the... 
Via TheNewswire.com
News headline image
NeuroOne(R) Regains Compliance With Nasdaq Listing Requirement
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
NeuroOne(R) Announces Chief Financial Officer Succession Plan
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Retirement
NeuroOne(R) Announces Chief Financial Officer Succession Plan
Ron McClurg to Retire as CFO Effective June 30 and Remain as Senior Advisor Through December 31 to Support Transition 
Via TheNewswire.com
Topics Retirement
News headline image
NeuroOne(R) to Report Second Quarter Fiscal Year 2026 Financial Results on Tuesday, May 12 at 8:30 a.m. Eastern Time
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Earnings
NeuroOne(R) to Report Second Quarter Fiscal Year 2026 Financial Results on Tuesday, May 12 at 8:30 a.m. Eastern Time
EDEN PRAIRIE, MINN. - April 28, 2026 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company dedicated to transforming the... 
Via TheNewswire.com
Topics Earnings
NeuroOne(R) Advances Brain Drug Delivery Platform Through Collaboration With University of Minnesota
sEEG-Based Drug Delivery System to be Utilized for Local Delivery of Novel Epilepsy Therapies 
Via TheNewswire.com
News headline image
NeuroOne(R) Advances Brain Drug Delivery Platform Through Collaboration With University of Minnesota
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
NeuroOne(R) Medical Technologies Announces Reverse Stock Split to Regain Nasdaq Compliance
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
NeuroOne(R) Medical Technologies Announces Reverse Stock Split to Regain Nasdaq Compliance
EDEN PRAIRIE, MINN. - April 14, 2026 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC), a medical technology company dedicated to transforming the surgical diagnosis and... 
Via TheNewswire.com
News headline image
NeuroOne(R) Medical Technologies Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
NeuroOne(R) Medical Technologies Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
EDEN PRAIRIE, MINN. - April 2, 2026 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC), a medical technology company dedicated to transforming the surgical diagnosis and... 
Via TheNewswire.com
News headline image
NeuroOne(R) Successfully Completes Limited Market Release of OneRF(R) Trigeminal Nerve Ablation System
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
NeuroOne(R) Successfully Completes Limited Market Release of OneRF(R) Trigeminal Nerve Ablation System
12 Patients Successfully Treated Across Three Leading Centers, With All Patients Reporting Freedom From Pain* 
Via TheNewswire.com
News headline image
NeuroOne(R) Announces Publication of Clinical Experience With Its OneRF(R) sEEG-Guided Radiofrequency Ablation Technology
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
NeuroOne(R) Announces Publication of Clinical Experience With Its OneRF(R) sEEG-Guided Radiofrequency Ablation Technology
Peer-Reviewed Case Series Supports Safe Integration into Existing Stereotactic Workflow, Bedside Treatment Capability, and Reductions in Seizure Burden in Patients with Drug-Resistant Epilepsy* 
Via TheNewswire.com
News headline image
NeuroOne(R) to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference March 17, 2026 at 1:20 p.m. Eastern Time
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
NeuroOne(R) to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference March 17, 2026 at 1:20 p.m. Eastern Time
EDEN PRAIRIE, MINN. - March 11, 2026 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company dedicated to transforming the... 
Via TheNewswire.com
News headline image
NeuroOne(R) Issues Shareholder Letter and Provides Corporate Update
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
NeuroOne(R) Appoints David Wambeke as Chief Business Officer; Concurrently Completes Insider Purchase of 1 Million Shares
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
NeuroOne(R) Appoints David Wambeke as Chief Business Officer; Concurrently Completes Insider Purchase of 1 Million Shares
Proven Healthcare Leader with Capital Markets Expertise to Support Strategic Expansion; Personal Investment Signals Strong Conviction in Company’s Strategic Growth 
Via TheNewswire.com
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.